FY2025 · period end Dec '25 · from the 10-K filed Feb 19, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $3.46B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000832101-26-000012 | May 6, 2026 | May 8, 2026 | May 8, 2026 17:36 UTC | EDGAR |
| 8-K | 0000832101-26-000007 | Apr 29, 2026 | Apr 29, 2026 | Apr 29, 2026 11:01 UTC | EDGAR |
| 10-Q | 0000832101-26-000009 | Mar 31, 2026 | Apr 29, 2026 | Apr 29, 2026 20:33 UTC | EDGAR |
| 10-K | 0000832101-26-000003 | Dec 31, 2025 | Feb 19, 2026 | Feb 19, 2026 21:33 UTC | EDGAR |
| 8-K | 0001193125-26-042918 | Feb 4, 2026 | Feb 9, 2026 | Feb 9, 2026 21:36 UTC | EDGAR |
| 8-K | 0001628280-26-005268 | Feb 4, 2026 | Feb 4, 2026 | Feb 4, 2026 12:00 UTC | EDGAR |
| 8-K | 0001193125-25-308187 | Dec 1, 2025 | Dec 4, 2025 | Dec 4, 2025 21:54 UTC | EDGAR |
| 8-K | 0001628280-25-046909 | Oct 29, 2025 | Oct 29, 2025 | Oct 29, 2025 11:08 UTC | EDGAR |
Direct links to SEC EDGAR. IEX has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Operating Income (Loss)·3 months to Dec 2016
Notable restatementwas$81.4M
Revised up in a 10-K.
Operating Income (Loss)·Q3 2016
Minor restatementwas$108.9M
Revised up in a 10-K.
Operating Income (Loss)·Q1 2016
Minor restatementwas$102.6M
Revised up in a 10-K.
Operating Income (Loss)·Q2 2016
Minor restatementwas$113M
Revised up in a 10-K.
Short-term Debt·As of Dec 31, 2020
Major restatementwas$88K
Revised up in a 10-K.
Long-term Debt, Excluding Current Maturities·As of Dec 31, 2014
Minor restatementwas$765M
Revised down in a 10-K.
IEX is not the only one.
See every restatement we've found across the market — or get an alert the next time IEX revises a number.
Restatements are detected by comparing every vintage of a fact across all of IDEX CORP /DE/'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows IEX's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling IDEX CORP /DE/ — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on IEX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on IEX and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $3.27B |
| $3.18B |
| $2.76B |
| Gross Profit | $1.54B | $1.45B | $1.45B | $1.43B | $1.22B |
|---|
| Operating Income | $0.70B | $0.68B | $0.73B | $0.75B | $0.64B |
|---|
| Net Income | $0.48B | $0.51B | $0.60B | $0.59B | $0.45B |
|---|
| EPS (Diluted) | $6.41 | $6.64 | $7.85 | $7.71 | $5.88 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $6.93B | $6.75B | $5.87B | $5.51B | $4.92B |
| Total Liabilities | $2.90B | $2.95B | $2.32B | $2.47B | $2.11B |
| Stockholders' Equity | $4.03B | $3.79B | $3.54B | $3.04B | $2.80B |
| Cash & Equivalents | $0.58B | $0.64B | $0.53B | $0.43B | $0.86B |
| Total Debt | $1.83B | $1.97B | $1.33B | $1.48B | $1.20B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $0.68B | $0.67B | $0.72B | $0.56B | $0.57B |
| Capital Expenditures | $0.06B | $0.07B | $0.09B | $0.07B | $0.07B |
| Free Cash Flow | $0.62B | $0.60B | $0.63B | $0.49B | $0.49B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 44.5% | 44.2% | 44.2% | 44.8% | 44.3% |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Net Margin | 0.1% | 0.2% | 0.2% | 0.2% | 0.2% |
| Return on Equity | 12.4% | 13.8% | 18.1% | 20.1% | 16.8% |
| Return on Assets | 7.1% | 8.0% | 10.5% | 11.3% | 9.6% |
| Debt / Equity | 0.45× | 0.52× | 0.38× | 0.49× | 0.43× |
